Lilly’s long-acting insulin wins NICE blessing ahead of potential UK approval
For patients living with Type 2 diabetes in the United Kingdom, a more convenient treatment option may be…
AstraZeneca settles Texas kickback lawsuit, agreeing to pay $34M
AstraZeneca will pay $34 million to resolve a lawsuit that alleged the company used illegal kickbacks to induce…
A merged AstraZeneca and BMS could lead Lilly on revenue until about 2030
In a potential marriage that analysts said faces long odds, AstraZeneca and Bristol Myers Squibb have held talks…
Top Healthcare Analyst: A $400 Billion AstraZeneca-Bristol Myers Deal Could “Cut Costs in a Big Way”
Quick Read BMY’s existing $2B cost-savings program and discounted forward P/E of ~10 make it an attractive AZN…
AstraZeneca’s Q2 net profit rises on strong cancer drug sales
AstraZeneca reconfirmed its full-year outlook after its Q2 profit beat analyst expectations. (EPA Images pic) LONDON: British pharmaceutical…
Encouraging trial results for AstraZeneca’s new weight-loss pill
PARIS — A new pill developed by the British pharma firm AstraZeneca appears to help people lose a…
AstraZeneca obesity pill helps patients lose 10.5% of body weight in trial
By Maggie Fick LONDON, June 8 (Reuters) – AstraZeneca said on Monday that patients lost 10.5% of their…
LLY Stock Climbs As Oral GLP-1 Pill Beats Novo Nordisk, AstraZeneca’s Therapies In Diabetes Trials
Lilly’s Foundayo outperformed existing treatments on blood sugar control and weight loss in type 2 diabetes patients in…